We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-4.38%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.27B
AUM Growth
-$371M
Cap. Flow
-$127M
Cap. Flow %
-2.97%
Top 10 Hldgs %
17.39%
Holding
1,495
New
92
Increased
565
Reduced
626
Closed
135
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QS icon
1301
QuantumScape Corp
QS
$3.84B
$97K ﹤0.01%
11,444
-10,296
-47% -$110K
VLDR
1302
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$96K ﹤0.01%
101,236
FUBO icon
1303
FuboTV Inc
FUBO
$283M
$95K ﹤0.01%
2,235
+894
+67% +$38.4K
ESRT icon
1304
Empire State Realty Trust
ESRT
$809M
$94K ﹤0.01%
14,355
MGF
1305
Aberdeen Government Markets Income Fund
MGF
$92.2M
$94K ﹤0.01%
28,786
+170
+0.6% +$596
AMRS
1306
DELISTED
Amyris Inc.
AMRS
$93K ﹤0.01%
31,822
-12,750
-29% -$34.8K
AEG icon
1307
Aegon
AEG
$14B
$86K ﹤0.01%
+21,546
New +$93.8K
OPTU
1308
Optimum Communications Inc
OPTU
$303M
$83K ﹤0.01%
+14,200
New +$136K
CLNN icon
1309
Clene
CLNN
$58.4M
$83K ﹤0.01%
1,476
-125
-8% -$8.28K
CRNT icon
1310
Ceragon Networks
CRNT
$203M
$82K ﹤0.01%
45,000
-4,000
-8% -$9.52K
PSEC icon
1311
Prospect Capital
PSEC
$1.15B
$82K ﹤0.01%
13,222
JMIA
1312
Jumia Technologies
JMIA
$746M
$81K ﹤0.01%
+13,919
New +$94.9K
BNGO icon
1313
Bionano Genomics
BNGO
$13.2M
$71K ﹤0.01%
65
+2
+3% +$2.64K
PFN
1314
PIMCO Income Strategy Fund II
PFN
$704M
$71K ﹤0.01%
+10,200
New +$79.2K
TCRR
1315
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$70K ﹤0.01%
38,950
+1,300
+3% +$3.77K
MFM
1316
Aberdeen Municipal Income Fund
MFM
$223M
$69K ﹤0.01%
14,297
VBIV
1317
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$68K ﹤0.01%
3,210
-50
-2% -$1.35K
PPT
1318
Franklin Premier Income Trust
PPT
$330M
$67K ﹤0.01%
18,600
FPL
1319
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
$66K ﹤0.01%
12,062
-1,906
-14% -$11.6K
TCRT icon
1320
Alaunos Therapeutics
TCRT
$4.84M
$63K ﹤0.01%
243
-60
-20% -$17.4K
MNKD icon
1321
MannKind Corp
MNKD
$1.26B
$61K ﹤0.01%
19,800
+3,000
+18% +$11.3K
IGR
1322
CBRE Global Real Estate Income Fund
IGR
$707M
$58K ﹤0.01%
10,072
-2,581
-20% -$18.9K
MBIO icon
1323
Mustang Bio
MBIO
$4.47M
$57K ﹤0.01%
161
+101
+168% +$46.8K
EAF icon
1324
GrafTech
EAF
$209M
$53K ﹤0.01%
1,240
+100
+9% +$6.36K
SPCE icon
1325
Virgin Galactic
SPCE
$480M
$51K ﹤0.01%
+544
New +$69.8K

Similar funds

Oppenheimer & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Oppenheimer & Co held 1,495 positions worth $4.27B, down 8% from $4.65B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2022 filing shows 92 new, 565 increased, 626 reduced and 135 closed positions. Its largest new stake was State Street SPDR Portfolio Mortgage Backed Bond ETF: 383,244 shares worth $8.22M. The largest sale was State Street SPDR Bloomberg 1-10 Year TIPS ETF, an estimated $11.6M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2022 buy was State Street SPDR Portfolio Mortgage Backed Bond ETF: 383,244 shares worth $8.22M.
  • Oppenheimer & Co added most to iShares 20+ Year Treasury Bond ETF in Q3 2022, an estimated $15.8M increase.
  • Oppenheimer & Co's biggest Q3 2022 reduction was State Street SPDR Bloomberg 1-10 Year TIPS ETF, cutting an estimated $11.6M.
  • Oppenheimer & Co fully exited iShares US Consumer Staples ETF in Q3 2022, selling an estimated $10.9M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.27B portfolio in Q3 2022.
  • Oppenheimer & Co opened 92 new positions and closed 135 in Q3 2022.
  • Oppenheimer & Co's portfolio value fell 8% quarter-over-quarter to $4.27B.

Based on Oppenheimer & Co's 13F filing for Q3 2022, filed 14 Nov 2022.